FdaApplication
NDA 202292
Identifiers
- fda_app_no: NDA202292
Properties
| Property | Value |
|---|---|
| applicant_name | NAPO PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2012-12-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MYTESI | CROFELEMER | 125MG | TABLET, DELAYED RELEASE;ORAL |
1 product